Glenmark also denied making any claims that “favipiravir alone” is effective in treatment of mild-to-moderate COVID-19 patients
21 Jul 2020 3:38 PM
Glenmark Pharmaceuticals had launched antiviral drug Favipiravir, under the brand name FabiFlu, last month at a price of Rs 103 per tablet
13 Jul 2020 2:53 PM